Interaction of human ACE2 to membrane-bound SARS-CoV-1 and SARS-CoV-2 S glycoproteins

Sai Priya Anand; Yaozong Chen; Jeremie Prevost; Romain Gasser; Guillaume Beaudoin-Bussieres; Cameron F Abrams; Marzena Pazgier; Andres Finzi.
Preprint en Inglés | PREPRINT-BIORXIV | ID: ppbiorxiv-286567

Documentos relacionados

  1. Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins.
  2. Mechanistic insights into ligand dissociation from the SARS-CoV-2 spike glycoprotein.
  3. Mechanisms of SARS-CoV-2 entry into cells.
  4. Dissection of Antibody Responses of Gam-COVID-Vac-Vaccinated Subjects Suggests Involvement of Epitopes Outside RBD in SARS-CoV-2 Neutralization.
  5. Structural basis of the American mink ACE2 binding by Y453F trimeric spike glycoproteins of SARS-CoV-2.
  6. The flexibility of ACE2 in the context of SARS-CoV-2 infection.
  7. The Life of SARS-CoV-2 Inside Cells: Replication-Transcription Complex Assembly and Function.
  8. Antibody-mediated SARS-CoV-2 entry in cultured cells.
  9. CLEC5A expression can be triggered by spike glycoprotein and may be a potential target for COVID-19 therapy.
  10. Microalgae as an Efficient Vehicle for the Production and Targeted Delivery of Therapeutic Glycoproteins against SARS-CoV-2 Variants.